Dabrafenib 75mg capsules
NHS hospitals in England used £41,394,151 of indicative cost of Dabrafenib 75mg capsules in the 12 months to April 2026, about 0.2% of all hospital medicines spend. That is down 6.0% on the previous 12 months.
Indicative cost · 12 months
Quantity (VMP units) · 12 months
Share of hospital medicines spend
Figure 1. Dabrafenib 75mg capsules: NHS hospital indicative cost by month (£ millions)
Source: NHSBSA Secondary Care Medicines Data, to April 2026
Cost is indicative — actual hospital medicine prices are commercially confidential, so these figures are estimated from list prices. See methodology.
NHS trusts using Dabrafenib 75mg capsules most
By indicative cost over the 12 months to April 2026.
| NHS trust | Indicative cost (12 months) |
|---|---|
| East And North Hertfordshire Nhs Trust | £2,354,800 |
| The Christie Nhs Foundation Trust | £1,989,600 |
| Leeds Teaching Hpls Nhs Trust | £1,808,800 |
| Nottingham University Hospitals Trust | £1,766,800 |
| Royal Surrey County Hosp Nhs Found Trust | £1,612,800 |
| Cambridge Univ Hosp Nhs Foundation Trust | £1,453,200 |
| Maidstone And Tunbridge Wells Nhs Trust | £1,426,600 |
| University Hospitals Dorset Nhs Ft | £1,391,600 |
| South Tees Hosp Nhs Foundation Trust | £1,318,800 |
| The Clatterbridge Cancer Centre Nhs Ft | £1,257,200 |
The primary-care picture
Dabrafenib is also dispensed in the community. See the national primary-care prescribing volume, cost and trend on the Dabrafenib medicine page.